Hospital Provincial De Conxo

Santiago De Compostela 9 trials 4 recruiting

9 Registered trials

4 Currently recruiting

Organisation

Hospital Provincial De Conxo

Location

Santiago De Compostela, Spain

Identifier

ORG-100023079

Address

Rua De Ramon Baltar Sn, 15706, Spain

Departments

Allergology
Allergy
Dermatology
Oftalmología
Ophtalmology
Ophthalmology
Servicio de Oftalmologia

Clinical trials at this site (9)

Search interface

Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy Pending

2023-505750-17-00 Neovascular age-related macular degeneration 4
A clinical trial to evaluate the efficacy and safety of a mixture of allergenic extracts of D. pteronyssinus and D. farinae, in patients suf… Pending

2025-521230-29-00 Allergic rhinoconjunctivitis to Dermatophagoides pteron 5
Darovasertib before Surgery or Radiation Therapy to Treat Early-stage Eye Cancer (Uveal Melanoma) Recruiting

2025-522387-32-00 Uveal Melanoma 5 2026-04-10
A trial to investigate teprotumumab mg/ml subcutaneous administration compared with placebo in male and female adult participants with moder… Recruiting

2024-515702-63-00 Moderate-to-Severe Active Thyroid Eye Disease 5 2025-02-20
A Phase 2a double blind, randomized, parallel arm, placebo-controlled trial to investigate the effects of two dose levels of CIT-013 on dise… Recruiting

2025-521684-12-00 Hidradenitis Suppurativa 4 2026-01-13
A Phase 3, multicenter, randomized, evaluator-blinded clinical trial to assess the safety and efficacy of Clobetasol propionate ophthalmic n… Recruiting

2024-513489-20-00 Inflammation and pain associated with ocular surgery 5 2022-11-21
A Randomized, Partially Masked, Controlled, Phase 3 Clinical Study to Evaluate the Efficacy and Safety of RGX-314 Gene Therapy in Participan… Ended

2023-503666-23-00 Neovascular age-related macular degeneration 5 2024-06-07
A study to evaluate Intravitreal JNJ-81201887(AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary… Ended

2022-500746-16-00 Geographic Atrophy 4 2023-08-11
Clinical trial to assess the efficacy and safety of a vaccine for dust mite allergy Ended

2024-514090-21-00 Aetiological treatment of moderate - severe intermitten 5 2020-08-05